Overview

Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male

Status:
COMPLETED
Trial end date:
2011-07-27
Target enrollment:
Participant gender:
Summary
pharmacokinetics, pharmacological effects and safety of multi dose of 7.5mg Tolvaptan tablet in healthy male subjects
Phase:
PHASE1
Details
Lead Sponsor:
Otsuka Beijing Research Institute
Treatments:
Tolvaptan